CHEST Physician
-
Positive results from TETON-1 trial introduce potential new therapy for IPF
Positive results from the TETON trials and expanding treatment options are encouraging for pulmonologists who are used to working with a limited toolkit for slowing disease progression in their patients with IPF.
-
Ventilatory management of immune checkpoint inhibitor pneumonitis
As immune checkpoint inhibitor use continues to expand, prospective data on phenotype-guided management and extracorporeal membrane oxygenation selection criteria are urgently needed.
-
Honoring a legacy, empowering the future
The John R. Addrizzo, MD, FCCP, Endowed Research Grant in Sarcoidosis, a transformative and permanent fund dedicated to advancing research in sarcoidosis, is not only a tribute to a beloved husband, father, grandfather, and physician but also a beacon for progress and discovery.
-
Top reads from the CHEST journal portfolio – July 2026
Read new research from the journal portfolio on antimicrobial treatment of mild MAC-PD, defining Meth-APAH, and liberal vs conservative fluid therapy in sepsis.
-
Coadministration safety of influenza, pertussis vaccines during pregnancy confirmed by large data set
Experts said the results, which showed no difference in outcomes such as preterm birth and low birth weight, may help improve prenatal vaccine uptake by reducing additional appointments for patients.
-
HI-PEITHO confirms benefit of USCDT in intermediate-risk pulmonary embolism
Investigator Frederikus A. Klok, MD, PhD, said he expects additional evidence to be published in the coming year, which will shape future guidelines and clinical management of patients with intermediate-high risk pulmonary embolism.
-
Study evaluates sleep efficiency change in patients with pediatric OSA following adenotonsillectomy
Pediatric pulmonologist Anne C. Coates, MD, said it may take longer to see a benefit from surgery in some populations, especially when nonrespiratory factors may be affecting sleep efficiency.
-
Advancing postarrest care in the ICU
New evidence suggests prophylactic antibiotics and biomarkers like neuron-specific enolase may help improve prevention and prognostication of cardiac arrest, offering a more proactive approach to postarrest care.
-
Steroids in pneumonia: The end of an era?
Emerging data suggest a potential expanding role for corticosteroids in severe cases of community-acquired pneumonia, though it remains uncertain whether this approach should extend to nonsevere or outpatient settings.
-
Mucus plugging in severe asthma: Clinical significance and emerging therapeutic targets
As image-based markers become increasingly integrated into severe asthma phenotyping, the mucus plug score may evolve into a clinically actionable tool.
